Tao Chen

High Impact

Role not yet determined Is this you? Add your title

NCTR

Also affiliated: Ningbo University (2024–2025); Tongji University (2006–2025); Beijing Tongren Hospital (2016); Fujian Medical University (2023); Apple (Israel) (2018); United States Food and Drug Administration (2025); Ministry of Education of the People's Republic of China (2018); Kyushu University (2001–2020); Harvard University (2016); Xidian University (2018); National University of Singapore (2019); City University of Hong Kong (2024–2025); Guangdong Medical College (2021); Second Military Medical University (2017); Zunyi Medical University (2019–2020); Shanghai Jiao Tong University (2025); Capital Medical University (2016); King's College London (2017); Chinese Center For Disease Control and Prevention (2012); Liverpool School of Tropical Medicine (2022); Chinese Academy of Medical Sciences & Peking Union Medical College (2011); Yichun University (2025); Southwestern University of Finance and Economics (2009); Sichuan University (2020–2025); Edinburgh Napier University (2012–2019); National Health and Family Planning Commission (2019); Diabetes Australia (2021); Chinese PLA General Hospital (2020–2024); Guangzhou Sport University (2025); Sichuan Agricultural University (2009); Haikou City People's Hospital (2014); West China Hospital of Sichuan University (2020–2025); Ganzhou People's Hospital (2024); Xinjiang Uygur Autonomous Region Disease Prevention and Control Center (2022); Jiangsu University of Science and Technology (2023–2024); Counseling Center (2020); 302 Military Hospital of China (2021); Gannan Medical University (2025); Changhai Hospital (2017); First Affiliated Hospital of Fujian Medical University (2023); First Affiliated Hospital of Xi'an Jiaotong University (2011–2019); Shanghai Pulmonary Hospital (2016–2025); State Council of the People's Republic of China (2019); Ningxia Medical University (2019); Hainan General Hospital (2014); Shanghai First People's Hospital (2025); Chinese Academy of Agricultural Sciences (2024); Sericultural Research Institute (2023–2025); People's Government of Shaanxi Province (2019); National Institute for Viral Disease Control and Prevention (2013–2019); Ministry of Education (2019); The First People's Hospital of Guiyang (2024); Ministry of Education (2019); Ministry of Agriculture and Rural Affairs (2024); Harvard Stem Cell Institute (2016); Second Affiliated Hospital of Zhejiang University (2021); Tongji Hospital (2020); Chinese People's Liberation Army (2020); Fu Wai Hospital (2009); Hainan 301 Hospital (2014); Affiliated Hospital of Zunyi Medical College (2019–2020); Dong-A University (2020); Chengdu University of Traditional Chinese Medicine (2022); Shandong Agricultural University (2019); University of Birmingham (2009); Xi'an Jiaotong University (2019); American College of Surgeons (2015)

29 h-index 151 pubs 2,729 cited

Upstream record may be merged OpenAlex, the source of these figures, lists 68 institutions in 11 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Tao Chen's research has investigated various aspects of human health, including susceptibility to exercise-induced muscle damage, determinants of cognitive performance and decline across diverse ethno-regional groups, and sex differences in dementia risk. Chen's work has also examined the relationship between sedentary behavior and metabolic syndrome in working adults. In addition, Chen has conducted studies on DNA adduct formation and mutation induction by aristolochic acid in animal models, and explored population aging, gender, and transportation systems.

Chen's scholarly contributions are reflected in a high-impact researcher designation, with a current h-index of 29, 151 total publications, and 2,729 citations. Key collaborators include Ying Chen, Robert H. Heflich, and Li Xia, all from the National Center for Toxicological Research, with whom Chen has co-authored multiple publications. Chen remains recently active, with the most recent publication listed as 2026.

Metrics

h-index: 29
Publications: 151
Citations: 2,729

Selected Publications

Key challenges for in vitro testing of tobacco and next generation products for regulatory applications: Recommendations for the Ames test (2026)

Alternatives to Laboratory Animals DOI OpenAlex
N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA (2025)

Chemico-Biological Interactions 2 citations DOI OpenAlex
Germline mutagenicity of molnupiravir and its active form, β-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing (2025)

Toxicology Letters 2 citations DOI OpenAlex
Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities (2025)

Toxicological Sciences 1 citation DOI OpenAlex
Application of duplex sequencing to evaluate mutagenicity of aristolochic acid and methapyrilene in Fisher 344 rats (2024)

Food and Chemical Toxicology 4 citations DOI OpenAlex